Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Melissa Burns, Yael Flamand, Lynda Vrooman, Victoria Koch, Sarah Cronholm, Sarah Hunt, Marian Harris, Peter Cole, Lisa Gennarini, Nobuko Hijiya, Justine Kahn, Kara Kelly, Bruno Michon, Donna Neuberg, Andrew Place, Thai Tran, Jennifer Welch, Stephen Sallan, Lewis Silverman

Blood (2025) 146 (Supplement 1): 644.

https://doi.org/10.1182/blood-2025-644

Published: 2025

Journal Articles

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Blood (2025) 146 (Supplement 1): 710.

https://doi.org/10.1182/blood-2025-710

Published: 2025

Journal Articles

Associations between serum asparaginase activity and asparaginase-associated toxicities in pediatric ALL patients receiving calaspargase: A report from the DFCI ALL consortium

Sara Mohamed, Yael Flamand, Victoria Koch, Lynda Vrooman, Peter Cole, Lisa Gennarini, Kara Kelly, Bruno Michon, Thai Hoa Tran, Jennifer Welch, Jeffrey Supko, Justine Kahn, Lewis Silverman

Blood (2025) 146 (Supplement 1): 5104.

https://doi.org/10.1182/blood-2025-5104

Published: 2025

Journal Articles

Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.

Jennifer Welch, Yael Flamand, Victoria Koch, Peter Cole, Lisa Gennarini, Justine Kahn, Kara Kelly, Bruno Michon, Thai Hoa Tran, Ilan Kirsch, Heidi Simmons, Melissa Burns, Lewis Silverman, Marian Harris

Blood (2025) 146 (Supplement 1): 5146.

https://doi.org/10.1182/blood-2025-5146

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Associations between serum asparaginase activity and asparaginase-associated toxicities in pediatric ALL patients receiving calaspargase: A report from the DFCI ALL consortium

Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.

Email alerts

ASH Publications

American Society of Hematology

Update search

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Associations between serum asparaginase activity and asparaginase-associated toxicities in pediatric ALL patients receiving calaspargase: A report from the DFCI ALL consortium

Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only